MEDIFAST INC Net Worth
MEDIFAST INC Net Worth Breakdown | MED |
MEDIFAST INC Net Worth Analysis
MEDIFAST INC's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including MEDIFAST INC's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of MEDIFAST INC's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform MEDIFAST INC's net worth analysis. One common approach is to calculate MEDIFAST INC's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares MEDIFAST INC's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing MEDIFAST INC's net worth. This approach calculates the present value of MEDIFAST INC's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of MEDIFAST INC's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate MEDIFAST INC's net worth. This involves comparing MEDIFAST INC's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into MEDIFAST INC's net worth relative to its peers.
Enterprise Value |
|
To determine if MEDIFAST INC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding MEDIFAST INC's net worth research are outlined below:
| MEDIFAST INC had very high historical volatility over the last 90 days | |
| Over 76.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Medifast Inc. Stock Analysis and Forecast - Free Stock Market Return Analysis - jammulinksnews.com |
MEDIFAST INC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in MEDIFAST INC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MEDIFAST INC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
MEDIFAST INC Target Price Consensus
MEDIFAST target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. MEDIFAST INC's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Hold |
Most MEDIFAST analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand MEDIFAST stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of MEDIFAST INC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMEDIFAST INC Target Price Projection
MEDIFAST INC's current and average target prices are 15.21 and 15.00, respectively. The current price of MEDIFAST INC is the price at which MEDIFAST INC is currently trading. On the other hand, MEDIFAST INC's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
MEDIFAST INC Market Quote on 24th of July 2025
Target Price
Analyst Consensus On MEDIFAST INC Target Price
Know MEDIFAST INC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Advisers, Llc | 2025-03-31 | 219 K | Two Sigma Investments Llc | 2025-03-31 | 216.7 K | Aqr Capital Management Llc | 2025-03-31 | 199.8 K | Man Group Plc | 2025-03-31 | 197 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 184.2 K | Federated Hermes Inc | 2025-03-31 | 175.8 K | Goldman Sachs Group Inc | 2025-03-31 | 172.2 K | Marshall Wace Asset Management Ltd | 2025-03-31 | 166.2 K | Jacobs Levy Equity Management, Inc. | 2025-03-31 | 143 K | Blackrock Inc | 2025-03-31 | 950.1 K | Renaissance Technologies Corp | 2025-03-31 | 888.9 K |
Follow MEDIFAST INC's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 167.17 M.Market Cap |
|
Project MEDIFAST INC's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
When accessing MEDIFAST INC's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures MEDIFAST INC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of MEDIFAST INC's profitability and make more informed investment decisions.
Please note, the presentation of MEDIFAST INC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIFAST INC's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIFAST INC's management manipulating its earnings.
Evaluate MEDIFAST INC's management efficiency
MEDIFAST INC has Return on Asset of 0.0133 % which means that on every $100 spent on assets, it made $0.0133 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0332) %, meaning that it generated no profit with money invested by stockholders. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. As of July 24, 2025, Return On Tangible Assets is expected to decline to 0.01. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 10.2 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 19.22 | 20.18 | |
| Tangible Book Value Per Share | 19.22 | 20.18 | |
| Enterprise Value Over EBITDA | 7.56 | 6.93 | |
| Price Book Value Ratio | 0.92 | 0.87 | |
| Enterprise Value Multiple | 7.56 | 6.93 | |
| Price Fair Value | 0.92 | 0.87 | |
| Enterprise Value | 397.2 M | 417.1 M |
MEDIFAST INC benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 0.0171 | Revenue | Quarterly Revenue Growth (0.34) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDIFAST INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDIFAST INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDIFAST INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MEDIFAST INC Corporate Filings
F4 | 26th of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 20th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of May 2025 Other Reports | ViewVerify | |
| 5th of May 2025 Other Reports | ViewVerify |
MEDIFAST INC Earnings Estimation Breakdown
The calculation of MEDIFAST INC's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of MEDIFAST INC is estimated to be -0.25 with the future projection ranging from a low of -0.25 to a high of -0.25. Please be aware that this consensus of annual earnings estimates for MEDIFAST INC is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.25 Lowest | Expected EPS | -0.25 Highest |
MEDIFAST INC Earnings Projection Consensus
Suppose the current estimates of MEDIFAST INC's value are higher than the current market price of the MEDIFAST INC stock. In this case, investors may conclude that MEDIFAST INC is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and MEDIFAST INC's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 1 | 40.42% | 0.0 | -0.25 | -0.64 |
MEDIFAST INC Earnings History
Earnings estimate consensus by MEDIFAST INC analysts from Wall Street is used by the market to judge MEDIFAST INC's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only MEDIFAST INC's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.MEDIFAST INC Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MEDIFAST INC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MEDIFAST INC Earnings per Share Projection vs Actual
Actual Earning per Share of MEDIFAST INC refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering MEDIFAST INC predict the company's earnings will be in the future. The higher the earnings per share of MEDIFAST INC, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.MEDIFAST INC Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as MEDIFAST INC, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of MEDIFAST INC should always be considered in relation to other companies to make a more educated investment decision.MEDIFAST Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact MEDIFAST INC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-04-28 | 2025-03-31 | 0.78 | -0.07 | -0.85 | 108 | ||
2025-02-18 | 2024-12-31 | 0.2424 | 0.1 | -0.1424 | 58 | ||
2024-11-04 | 2024-09-30 | -0.28 | 0.35 | 0.63 | 225 | ||
2024-08-05 | 2024-06-30 | 0.39 | 0.92 | 0.53 | 135 | ||
2024-04-29 | 2024-03-31 | 0.78 | 0.66 | -0.12 | 15 | ||
2024-02-20 | 2023-12-31 | 0.96 | 0.55 | -0.41 | 42 | ||
2023-11-06 | 2023-09-30 | 1.07 | 2.12 | 1.05 | 98 | ||
2023-08-07 | 2023-06-30 | 1.44 | 2.77 | 1.33 | 92 | ||
2023-05-01 | 2023-03-31 | 2.4 | 3.67 | 1.27 | 52 | ||
2023-02-21 | 2022-12-31 | 2.22 | 3.27 | 1.05 | 47 | ||
2022-11-03 | 2022-09-30 | 1.91 | 3.27 | 1.36 | 71 | ||
2022-08-03 | 2022-06-30 | 3.23 | 3.42 | 0.19 | 5 | ||
2022-05-02 | 2022-03-31 | 3.57 | 3.59 | 0.02 | 0 | ||
2022-02-23 | 2021-12-31 | 2.65 | 2.91 | 0.26 | 9 | ||
2021-11-04 | 2021-09-30 | 3.08 | 3.56 | 0.48 | 15 | ||
2021-08-04 | 2021-06-30 | 3.32 | 3.96 | 0.64 | 19 | ||
2021-05-04 | 2021-03-31 | 2.73 | 3.46 | 0.73 | 26 | ||
2021-02-25 | 2020-12-31 | 2.38 | 2.36 | -0.02 | 0 | ||
2020-11-02 | 2020-09-30 | 2.46 | 2.91 | 0.45 | 18 | ||
2020-08-05 | 2020-06-30 | 1.83 | 1.96 | 0.13 | 7 | ||
2020-05-05 | 2020-03-31 | 1.33 | 1.93 | 0.6 | 45 | ||
2020-02-26 | 2019-12-31 | 1.07 | 1.66 | 0.59 | 55 | ||
2019-11-07 | 2019-09-30 | 1.34 | 1.32 | -0.02 | 1 | ||
2019-08-01 | 2019-06-30 | 1.72 | 1.75 | 0.03 | 1 | ||
2019-05-01 | 2019-03-31 | 1.54 | 1.7 | 0.16 | 10 | ||
2019-02-26 | 2018-12-31 | 1.21 | 1.3 | 0.09 | 7 | ||
2018-11-06 | 2018-09-30 | 1.14 | 1.14 | 0.0 | 0 | ||
2018-08-02 | 2018-06-30 | 1 | 1.16 | 0.16 | 16 | ||
2018-05-03 | 2018-03-31 | 0.86 | 1.01 | 0.15 | 17 | ||
2018-03-06 | 2017-12-31 | 0.48 | 0.6 | 0.12 | 25 | ||
2017-11-07 | 2017-09-30 | 0.51 | 0.55 | 0.04 | 7 | ||
2017-08-08 | 2017-06-30 | 0.52 | 0.63 | 0.11 | 21 | ||
2017-05-04 | 2017-03-31 | 0.47 | 0.51 | 0.04 | 8 | ||
2017-03-09 | 2016-12-31 | 0.33 | 0.34 | 0.01 | 3 | ||
2016-11-03 | 2016-09-30 | 0.45 | 0.51 | 0.06 | 13 | ||
2016-08-03 | 2016-06-30 | 0.51 | 0.63 | 0.12 | 23 | ||
2016-05-04 | 2016-03-31 | 0.33 | 0.42 | 0.09 | 27 | ||
2016-03-10 | 2015-12-31 | 0.35 | 0.33 | -0.02 | 5 | ||
2015-11-05 | 2015-09-30 | 0.42 | 0.45 | 0.03 | 7 | ||
2015-08-05 | 2015-06-30 | 0.48 | 0.48 | 0.0 | 0 | ||
2015-05-07 | 2015-03-31 | 0.35 | 0.46 | 0.11 | 31 | ||
2015-03-12 | 2014-12-31 | 0.46 | 0.38 | -0.08 | 17 | ||
2014-11-05 | 2014-09-30 | 0.36 | 0.39 | 0.03 | 8 | ||
2014-08-07 | 2014-06-30 | 0.39 | 0.44 | 0.05 | 12 | ||
2014-05-05 | 2014-03-31 | 0.36 | 0.45 | 0.09 | 25 | ||
2014-03-10 | 2013-12-31 | 0.36 | 0.39 | 0.03 | 8 | ||
2013-11-05 | 2013-09-30 | 0.42 | 0.41 | -0.01 | 2 | ||
2013-08-06 | 2013-06-30 | 0.51 | 0.51 | 0.0 | 0 | ||
2013-05-08 | 2013-03-31 | 0.34 | 0.43 | 0.09 | 26 | ||
2013-03-07 | 2012-12-31 | 0.25 | 0.28 | 0.03 | 12 | ||
2012-11-05 | 2012-09-30 | 0.4 | 0.42 | 0.02 | 5 | ||
2012-07-26 | 2012-06-30 | 0.37 | 0.46 | 0.09 | 24 | ||
2012-05-08 | 2012-03-31 | 0.37 | 0.32 | -0.05 | 13 | ||
2012-03-13 | 2011-12-31 | 0.21 | 0.09 | -0.12 | 57 | ||
2011-11-03 | 2011-09-30 | 0.37 | 0.36 | -0.01 | 2 | ||
2011-08-04 | 2011-06-30 | 0.47 | 0.41 | -0.06 | 12 | ||
2011-05-09 | 2011-03-31 | 0.41 | 0.44 | 0.03 | 7 | ||
2011-03-31 | 2010-12-31 | 0.32 | 0.23 | -0.09 | 28 | ||
2010-11-04 | 2010-09-30 | 0.39 | 0.39 | 0.0 | 0 | ||
2010-08-05 | 2010-06-30 | 0.34 | 0.38 | 0.04 | 11 | ||
2010-05-05 | 2010-03-31 | 0.27 | 0.33 | 0.06 | 22 | ||
2010-03-04 | 2009-12-31 | 0.19 | 0.21 | 0.02 | 10 | ||
2009-10-29 | 2009-09-30 | 0.19 | 0.23 | 0.04 | 21 | ||
2009-07-30 | 2009-06-30 | 0.17 | 0.2 | 0.03 | 17 | ||
2009-04-29 | 2009-03-31 | 0.12 | 0.17 | 0.05 | 41 | ||
2009-03-12 | 2008-12-31 | 0.08 | 0.07 | -0.01 | 12 | ||
2008-11-06 | 2008-09-30 | 0.11 | 0.11 | 0.0 | 0 | ||
2008-08-07 | 2008-06-30 | 0.09 | 0.11 | 0.02 | 22 | ||
2008-05-12 | 2008-03-31 | 0.11 | 0.1 | -0.01 | 9 | ||
2008-03-12 | 2007-12-31 | 0.06 | 0.04 | -0.02 | 33 | ||
2007-11-08 | 2007-09-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2007-08-09 | 2007-06-30 | 0.1 | 0.07 | -0.03 | 30 | ||
2007-05-10 | 2007-03-31 | 0.14 | 0.1 | -0.04 | 28 | ||
2007-03-16 | 2006-12-31 | 0.05 | 0.03 | -0.02 | 40 | ||
2006-11-14 | 2006-09-30 | 0.09 | 0.11 | 0.02 | 22 | ||
2006-08-14 | 2006-06-30 | 0.11 | 0.11 | 0.0 | 0 | ||
2006-05-15 | 2006-03-31 | 0.07 | 0.13 | 0.06 | 85 | ||
2006-03-15 | 2005-12-31 | 0.03 | 0.07 | 0.04 | 133 | ||
2005-11-09 | 2005-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2005-08-09 | 2005-06-30 | 0.06 | 0.06 | 0.0 | 0 | ||
2005-05-10 | 2005-03-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2005-03-14 | 2004-12-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2004-11-15 | 2004-09-30 | 0.06 | 0.03 | -0.03 | 50 | ||
2004-08-16 | 2004-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2004-05-12 | 2004-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2004-03-15 | 2003-12-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2003-11-13 | 2003-09-30 | 0.06 | 0.04 | -0.02 | 33 | ||
2003-08-14 | 2003-06-30 | 0.08 | 0.05 | -0.03 | 37 | ||
2003-05-05 | 2003-03-31 | 0.06 | 0.08 | 0.02 | 33 |
MEDIFAST INC Corporate Directors
| Ming Xian | Independent Director | Profile | |
| Michael Hoer | Independent Director | Profile | |
| Jeffrey Brown | Lead Independent Director | Profile | |
| Scott Schlackman | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share (0.64) | Revenue Per Share | Quarterly Revenue Growth (0.34) | Return On Assets |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.